News
Analysts are mostly upbeat about Sime Darby Property Bhd's (SimeProp) strategic joint-venture (JV) with its sister company SD ...
16h
Khaleej Times on MSNDubai becoming the top legacy hub for African super-richFor African investors, the UAE presents a seamless path with its transparent legal environment, absence of capital gains and ...
BAKU, Azerbaijan, June 23. The Azerbaijan Export and Investment Promotion Agency (AZPROMO) and Black Locust Capital ...
Bhagya Laxmi Vangala is an experienced data engineering architect with more than 16 years of experience specializing in ...
Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...
June 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council ...
How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical ...
20h
Vietnam Investment Review on MSNCyberway platform fuels product innovation for global enterprisesIn the fiercely competitive FMCG market, only efficient innovation can create a true competitive edge. As consumer preferences change rapidly and the market environment remains uncertain, how can ...
16h
Zacks Investment Research on MSNCNQ to Divest Seiu Lake Stake to Secure SLB's Asset AcquisitionCanadian Natural Resources Limited CNQ, a Calgary-based oil and gas exploration and production firm, has strategically agreed to divest a majority interest in the Seiu Lake natural gas processing ...
The company and its part are developing a digital 'super corridor' that will enable direct access for European entities to ...
4h
Interesting Engineering on MSNFeatherlight nanomaterial pulls clean drinking water from air, absorbs 3x its weightFeatherlight nanomaterial built from graphene and calcium pulls clean water from the air with unmatched efficiency.
Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results